Company · CIK 0001267813 · SIC 2834 — Pharmaceutical Preparations
MARINUS PHARMACEUTICALS INC · MRNS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2019 SForm 4 → | Jan 30, 4:08 pm EST | Edward F SmithCFO | 2,492 | $3.06 | $7,626 | 44,308 | −5.32% | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 4:09 pm EST | Christopher Michael CashmanCEO, Director | 8,142 | $3.13 | $25,484 | 239,761 | −3.28% | plan? |
| Jan 29, 2018 SForm 4 → | Jan 29, 8:00 pm EST | Edward F SmithCFO | 3,000 | $7.91 | $23,730 | 49,800 | −5.68% | plan? |
| Jan 22, 2018 JForm 4 → | Jan 24, 4:09 pm EST | Nicole VitulloDirector | 4,500 | — | — | 46,450 | — | plan? |
| Jan 18, 2018 SForm 4 → | Jan 22, 8:41 pm EST | Christopher Michael CashmanCEO, Director | 9,566 | $6.28 | $60,074 | 247,903 | −3.72% | plan? |
| Dec 15, 2017 SForm 4 → | Dec 19, 8:30 pm EST | Bain Capital Life Sciences Investors, LLC +510% Owner | 1,272,547 | $7.88 | $10,024,801 | 3,977,453 | −24.2% | plan? |
| Sep 11, 2017 JForm 4 → | Sep 11, 5:25 pm EDT | Nicole VitulloDirector | 3,300 | — | — | 44,200 | — | plan? |
| Jan 17, 2017 AForm 4/A → | Jan 29, 2018, 8:03 pm EST | Timothy M MaylebenDirector | 4,500 | — | — | 50,350 | — | plan? |
| Jan 17, 2017 AForm 4/A → | Jan 29, 2018, 8:02 pm EST | Enrique J. CarrazanaDirector | 28,500 | — | — | 31,800 | — | plan? |
| Jan 17, 2017 AForm 4/A → | Jan 29, 2018, 8:00 pm EST | Edward F SmithCFO | 25,200 | — | — | 52,800 | — | plan? |
| Jan 17, 2017 AForm 4/A → | Jan 22, 2018, 8:38 pm EST | Christopher Michael CashmanCEO, Director | 60,600 | — | — | 257,469 | — | plan? |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:42 pm EST | Nicole VitulloDirector, 10% Owner | 4,500 | — | — | 7,800 | — | plan? |
| Oct 20, 2016 SForm 4 → | Oct 24, 4:49 pm EDT | Anand Mehra +810% Owner | 750,683 | $1.39 | $1,042,699 | 15,470 | −98.0% | plan? |
| Aug 5, 2016 SForm 4 → | Aug 9, 10:03 am EDT | Canaan VII LP +110% Owner | 149,154 | $1.50 | $223,731 | 1,850,783 | −7.46% | plan? |
| Aug 3, 2016 AForm 4/A → | Jan 29, 2018, 8:03 pm EST | Timothy M MaylebenDirector | 3,300 | — | — | 45,850 | — | plan? |
| Aug 3, 2016 AForm 4/A → | Jan 29, 2018, 8:02 pm EST | Enrique J. CarrazanaDirector | 3,300 | — | — | 3,300 | — | plan? |
| Aug 3, 2016 AForm 4/A → | Jan 29, 2018, 8:01 pm EST | Edward F SmithCFO | 27,600 | — | — | 27,600 | — | plan? |
| Aug 3, 2016 AForm 4/A → | Jan 22, 2018, 8:44 pm EST | Christopher Michael CashmanCEO, Director | 56,100 | — | — | 196,869 | — | plan? |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:00 pm EDT | Nicole VitulloDirector, 10% Owner | 3,300 | — | — | 3,300 | — | plan? |
| Aug 3, 2016 SForm 4 → | Aug 5, 10:18 am EDT | Canaan VII LP +110% Owner | 145,583 | $1.50 | $218,375 | 1,999,937 | −6.79% | plan? |
| Jul 29, 2016 SForm 4 → | Aug 2, 12:22 pm EDT | Canaan VII LP +110% Owner | 24,540 | $1.71 | $41,963 | 2,145,520 | −1.13% | plan? |
| Jul 26, 2016 SForm 4 → | Jul 27, 4:30 pm EDT | Canaan VII LP +110% Owner | 20,589 | $1.81 | $37,264 | 2,170,060 | −0.94% | plan? |
| Jul 22, 2016 SForm 4 → | Jul 26, 10:08 am EDT | Canaan VII LP +110% Owner | 270,750 | $1.90 | $514,246 | 2,190,649 | −11.0% | plan? |
| Feb 9, 2016 MForm 4 → | Feb 11, 5:17 pm EST | Christopher Michael CashmanPresident and CEO, Director | 24,684 | $1.04 | $25,671 | 140,769 | — | plan? |
| Nov 6, 2015 PForm 4 → | Feb 11, 2016, 5:17 pm EST | Christopher Michael CashmanPresident and CEO, Director | 3,561 | $5.61 | $19,977 | 116,085 | +3.16% | plan? late |
| Sep 28, 2015 MForm 4/A → | Feb 4, 2016, 6:48 pm EST | Stephen M BlochDirector | 39,550 | $1.04 | $41,132 | 39,550 | — | plan? |
| Sep 28, 2015 MForm 4 → | Sep 28, 8:12 pm EDT | Stephen M BlochDirector | 39,550 | $1.04 | $41,132 | 39,550 | — | plan? amended |
| Jul 16, 2015 MForm 4 → | Jul 17, 4:01 pm EDT | Timothy M MaylebenDirector | 42,550 | $1.04 | $44,252 | 42,550 | — | plan? |
| Jul 1, 2015 MForm 4 → | Jul 2, 4:08 pm EDT | Christopher Michael CashmanPresident and CEO, Director | 14,086 | $1.04 | $14,649 | 112,524 | — | plan? |
| Jun 10, 2015 GMForm 4 → | Jun 11, 5:26 pm EDT | Stephen M BlochDirector | 6,000 | $1.04 | $3,120 | 0 | — | plan? |
| Apr 21, 2015 SForm 4 → | Apr 23, 4:48 pm EDT | Gail M FarfelChief Clinical Dev & Reg Offic | 30,000 | $9.48 | $284,511 | 0 | −100% | plan? |
| Apr 21, 2015 MForm 4 → | Apr 23, 4:48 pm EDT | Gail M FarfelChief Clinical Dev & Reg Offic | 30,000 | $1.04 | $31,200 | 30,000 | — | plan? |
| Mar 6, 2015 MForm 4 → | Mar 10, 1:16 pm EDT | Christopher Michael CashmanPRESIDENT AND CEO, Director | 17,608 | $1.04 | $18,312 | 98,438 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2019 AForm 4 → | Feb 28, 7:00 pm EST | Edward F SmithCFO | 200,000 | — | — | 200,000 | — | |
| Feb 26, 2019 AForm 4 → | Feb 28, 7:00 pm EST | Masuoka K. LorianneChief Medical Officer | 200,000 | — | — | 200,000 | — | |
| Feb 26, 2019 AForm 4 → | Feb 28, 6:59 pm EST | Michael R DoughertyDirector | 35,000 | — | — | 35,000 | — | |
| Feb 26, 2019 AForm 4 → | Feb 28, 6:59 pm EST | Seth H. Z. FischerDirector | 35,000 | — | — | 35,000 | — | |
| Feb 26, 2019 AForm 4 → | Feb 28, 6:58 pm EST | Timothy M MaylebenDirector | 35,000 | — | — | 35,000 | — | |
| Feb 26, 2019 AForm 4 → | Feb 28, 6:58 pm EST | Scott BraunsteinExecutive Chairman, Director | 240,000 | — | — | 240,000 | — | |
| Feb 26, 2019 AForm 4 → | Feb 28, 6:57 pm EST | Enrique J. CarrazanaDirector | 65,000 | — | — | 65,000 | — | |
| Feb 26, 2019 AForm 4 → | Feb 28, 5:21 pm EST | Nicole VitulloDirector | 35,000 | — | — | 35,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:19 pm EST | Nicole VitulloDirector | 35,000 | — | — | 35,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:06 pm EST | Timothy M MaylebenDirector | 35,000 | — | — | 35,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:06 pm EST | Masuoka K. LorianneChief Medical Officer | 150,000 | — | — | 150,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:05 pm EST | Seth H. Z. FischerDirector | 35,000 | — | — | 35,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:05 pm EST | Michael R DoughertyDirector | 35,000 | — | — | 35,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:05 pm EST | Christopher Michael CashmanCEO, Director | 500,000 | — | — | 500,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:04 pm EST | Enrique J. CarrazanaDirector | 35,000 | — | — | 35,000 | — | |
| Dec 6, 2017 AForm 4 → | Dec 8, 4:04 pm EST | Edward F SmithCFO | 200,000 | — | — | 200,000 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:20 pm EST | Edward F SmithCFO | 84,000 | — | — | 25,200 | — | amended |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:20 pm EST | Jay ShepardDirector | 15,000 | — | — | 4,500 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:19 pm EST | Timothy M MaylebenDirector | 15,000 | — | — | 4,500 | — | amended |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:19 pm EST | Seth H. Z. FischerDirector | 15,000 | — | — | 4,500 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:19 pm EST | Christopher Michael CashmanChairman and CEO, Director | 202,000 | — | — | 60,600 | — | amended |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:19 pm EST | Enrique J. CarrazanaDirector | 95,000 | — | — | 28,500 | — | amended |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:42 pm EST | Nicole VitulloDirector, 10% Owner | 10,500 | — | — | 10,500 | — | |
| Aug 3, 2016 AForm 4 → | Aug 5, 7:32 pm EDT | Anand MehraDirector | 11,000 | — | — | 3,300 | — | |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:21 pm EDT | Jay ShepardDirector | 11,000 | — | — | 3,300 | — | |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:21 pm EDT | Albena PatronevaChief Medical Officer | 69,000 | — | — | 20,700 | — | |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:21 pm EDT | Timothy M MaylebenDirector | 11,000 | — | — | 3,300 | — | amended |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:20 pm EDT | Christopher Michael CashmanChairman and CEO, Director | 187,000 | — | — | 56,100 | — | amended |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:20 pm EDT | Enrique J. CarrazanaDirector | 11,000 | — | — | 3,300 | — | amended |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:20 pm EDT | Edward F SmithCFO | 82,000 | — | — | 24,600 | — | amended |
| Aug 3, 2016 AForm 4 → | Aug 5, 5:00 pm EDT | Nicole VitulloDirector, 10% Owner | 7,700 | — | — | 7,700 | — | |
| Feb 9, 2016 MForm 4 → | Feb 11, 5:17 pm EST | Christopher Michael CashmanPresident and CEO, Director | 24,684 | — | — | 31,662 | — | |
| Feb 4, 2016 AForm 4 → | Feb 10, 4:01 pm EST | Enrique J. CarrazanaDirector | 25,000 | — | — | 25,000 | — | late |
| Sep 24, 2015 AMForm 4/A → | Feb 4, 2016, 6:48 pm EST | Stephen M BlochDirector | 45,850 | — | — | 0 | — | |
| Sep 24, 2015 AMForm 4 → | Sep 28, 8:12 pm EDT | Stephen M BlochDirector | 45,850 | — | — | 0 | — | amended |
| Jul 20, 2015 AForm 4 → | Jul 22, 8:57 pm EDT | Anand MehraDirector, 10% Owner | 6,300 | — | — | 6,300 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 5:46 pm EDT | Nicole VitulloDirector, 10% Owner | 6,300 | — | — | 6,300 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 4:04 pm EDT | Christopher Michael CashmanPresident and CEO, Director | 160,000 | — | — | 160,000 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 4:03 pm EDT | Albena PatronevaChief Medical Officer | 50,000 | — | — | 50,000 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 4:03 pm EDT | Edward F SmithCFO | 70,000 | — | — | 70,000 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 4:02 pm EDT | Enrique J. CarrazanaDirector | 6,300 | — | — | 6,300 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 4:02 pm EDT | Timothy M MaylebenDirector | 6,300 | — | — | 6,300 | — | |
| Jul 20, 2015 AForm 4 → | Jul 22, 4:01 pm EDT | Jay ShepardDirector | 6,300 | — | — | 6,300 | — | |
| Jul 16, 2015 MForm 4 → | Jul 17, 4:01 pm EDT | Timothy M MaylebenDirector | 42,550 | — | — | 0 | — | |
| Jul 1, 2015 MForm 4 → | Jul 2, 4:08 pm EDT | Christopher Michael CashmanPresident and CEO, Director | 14,086 | — | — | 56,346 | — | |
| Jun 10, 2015 MForm 4 → | Jun 11, 5:26 pm EDT | Stephen M BlochDirector | 3,000 | — | — | 12,515 | — | |
| Apr 21, 2015 MForm 4 → | Apr 23, 4:48 pm EDT | Gail M FarfelChief Clinical Dev & Reg Offic | 30,000 | — | — | 8,462 | — | |
| Mar 6, 2015 MForm 4 → | Mar 10, 1:16 pm EDT | Christopher Michael CashmanPRESIDENT AND CEO, Director | 17,608 | — | — | 70,432 | — | |
| Dec 31, 2014 AForm 4 → | Jan 7, 2015, 6:03 am EST | Albena PatronevaChief Medical Officer | 158,000 | — | — | 158,000 | — | late |
| Sep 30, 2014 AForm 4/A → | Feb 4, 2016, 6:49 pm EST | Canaan VII LP +1Director, 10% Owner | 6,000 | — | — | 6,000 | — |